Literature DB >> 6260587

DNA modification induced during infection of Bacillus subtilis by phage phi 3T.

J M Cregg, A H Nguyen, J Ito.   

Abstract

The DNA of the Bacillus subtilis temperate phage phi 3T is not susceptible to cleavage by the restriction endonuclease HaeIII, although it is cut by many other restriction enzymes. The host DNA from uninfected cells is cut by HaeIII. We show that phi 3T DNA propagated in a restriction-modification-defective Escherichia coli cell can be digested by HaeIII. Thus, phi 3T DNA does contain the nucleotide recognition sequence of HaeIII. We suggest that this phage induces the modification of its own DNA. In support of this mechanism we show that extracts prepared from phi 3T-infected cells contain an activity which in the presence of S-adenosyl-L-methionine (SAM) can modify lambda DNA against cleavage by HaeIII. The same in vitro-modified DNA is still susceptible to cleavage by other restriction endonucleases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6260587     DOI: 10.1016/0378-1119(80)90011-6

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  4 in total

1.  Restriction and modification in Bacillus subtilis: sequence specificities of restriction/modification systems BsuM, BsuE, and BsuF.

Authors:  S Jentsch
Journal:  J Bacteriol       Date:  1983-11       Impact factor: 3.490

2.  Restriction and modification in Bacillus subtilis: gene coding for a BsuR-specific modification methyltransferase in the temperate bacteriophage phi 3T.

Authors:  M Noyer-Weidner; B Pawlek; S Jentsch; U Günthert; T A Trautner
Journal:  J Virol       Date:  1981-06       Impact factor: 5.103

Review 3.  Bacteriophage survival: multiple mechanisms for avoiding the deoxyribonucleic acid restriction systems of their hosts.

Authors:  D H Krüger; T A Bickle
Journal:  Microbiol Rev       Date:  1983-09

4.  Restriction and modification in Bacillus subtilis: DNA methylation potential of the related bacteriophages Z, SPR, SP beta, phi 3T, and rho 11.

Authors:  M Noyer-Weidner; S Jentsch; B Pawlek; U Günthert; T A Trautner
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.